Entheon Biomedical Corp. (CNSX:ENBI) is a biotechnology research and development company interested in treating addiction and substance use disorders.
Entheon Biomedical
CNSX:ENBI ISIN:CA29383X1116
News
Join Ellis Martin for a conversation with Timothy Ko, the CEO of Entheon Biomedical (CNSX:ENBI) (OTCMKTS:ENTBF). Entheon Biomedical is pioneering a leading-edge addiction recovery solution that harnesses and optimizes the therapeutic potential of the DMT molecule.
Entheon Biomedical is pioneering a leading-edge addiction recovery solution that harnesses and optimizes the therapeutic potential of the DMT molecule. Entheon exists to invert the addiction-recovery ratio, turning the 'untreatable case' and 'lost cause' from the norm to the exception.
###
3,309 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 6) (Last 30 Days: 29) (Since Published: 3309)
